No Data
RBC Capital Sticks to Its Hold Rating for PTC Therapeutics (PTCT)
Form 144 | PTC Therapeutics(PTCT.US) Director Proposes to Sell 764.77K in Common Stocks
SEC FILLINGS DISCLOSED/ May 22, $PTC Therapeutics(PTCT.US)$ Director ZELDIS JEROME B intends to sell 20,000 shares of its common stock on May 22, with a total market value of approximately $764.77K.
Analysts' Revenue Estimates For PTC Therapeutics, Inc. (NASDAQ:PTCT) Are Surging Higher
PTC Therapeutics, Inc. (NASDAQ:PTCT) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's statutory forecasts. The consensus estimated revenue
Hold Rating on PTC Therapeutics Amid Regulatory Uncertainty for Translarna
PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug
PTC Therapeutics Price Target Raised to $53.00/Share From $43.00 by JP Morgan
PTC Therapeutics Price Target Raised to $53.00/Share From $43.00 by JP Morgan